Potassium Citrate
23 NDCs across 10 manufacturers|21 Generic,2 Brand
Potassium Citrate is used to treat renal tubular acidosis, hypokalemia and lithiasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 30, 1985, and the first generic was approved Jun 8, 2006. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $50 million on Potassium Citrate across 531,000 claims for 145,000 beneficiaries.
Potassium Citrate is available as 23 NDCs from 10 manufacturers (21 generic, 2 brand), with NADAC prices from $0.12 to $3.55 per EA — the most expensive product costs about 29× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
21G / 2B
Manufacturers
10
competing in market
Price Spread
$0.12 – $3.55
per EA
7d Activity
avg -4.3% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Actavis Pharma, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anti-coagulant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing POTASSIUM CITRATE(1 pricing outlier)
Frequently Asked Questions
What is Potassium Citrate used to treat?
Potassium Citrate is used to treat renal tubular acidosis, hypokalemia and lithiasis, per the National Library of Medicine's MED-RT classification.
When did Potassium Citrate become available as a generic?
FDA approved the first generic Potassium Citrate (ANDA) on Jun 8, 2006. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Potassium Citrate?
In 2024, Medicare Part D spent $50 million on Potassium Citrate across 531,000 claims for 145,000 beneficiaries.
How many Potassium Citrate products are on the market?
The Potassium Citrate drug market contains 23 NDCs from 10 manufacturers — 21 generic and 2 brand products.
What is the price range for Potassium Citrate?
NADAC reference prices for Potassium Citrate range from $0.1235 to $3.5507 per EA — the most expensive product costs about 29× the cheapest.
Is generic Potassium Citrate cheaper than brand?
The average generic NADAC for Potassium Citrate is $0.1601 per EA, versus $2.8181 for brand-labeled products — brand versions average about 18× the generic price.
Which manufacturers make Potassium Citrate?
10 manufacturers list Potassium Citrate in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (3), Strides Pharma Inc. (3), Camber Pharmaceuticals Inc. (3), Zydus Pharmaceuticals (USA) Inc. (3), Mission Pharmacal Company (2).
How has the price of Potassium Citrate changed recently?
Over the past 7 days, 0 Potassium Citrate NDCs rose and 42 fell, with a market-wide average change of -4.3%.